SC
Scope Fluidics S.A.
SCP.WA · WSE
130.00 zł +0.93% (+1.20 zł)
1M -1.55%
Market Cap 405.5M zł
P/E Ratio -
Div. Yield -
ROE 35.65%
Bulios Fair Price
96.07 zł
26.1% downside
Current Price
130 zł
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SCP.WA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
84 /100
Cheap P/B 2.92x
P/S -784.41x
PEG N/A
Growth
0 /100
Declining Book val. growth 21.28%
Rev. growth 37.21%
FCF growth N/A
Profitability
100 /100
Strong FCF margin 11,536.80%
Op. margin 10,809.90%
Gross margin 12,985.30%
Quality
0 /100
Poor Asset turnover -0.00x
ROA 29.52%
ROIC 36.00%
Debt
69 /100
Low Current ratio 10.52x
Int. coverage -226.38x
Debt/Equity 0.12x
Stability
1 /100
Unstable Profitable years 0
EPS volatility 339.92%
Beta 0.00x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SCP.WA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Piotr Garstecki
Employees
157
Headquarters
Warsaw
Upcoming events
07 DEC
Earnings
Upcoming earnings report